Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma

por Baldan, V, Griffiths, R, Hawkins, R E, Gilham, D E
Publicado 2015

Engineering T cells for cancer therapy

por Mansoor, W, Gilham, D E, Thistlethwaite, F C, Hawkins, R E
Publicado 2005

T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches

por Sheen, A J, Sherlock, D J, Irlam, J, Hawkins, R E, Gilham, D E
Publicado 2003

CD3ζ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell ther...

por Bridgeman, J S, Ladell, K, Sheard, V E, Miners, K, Hawkins, R E, Price, D A, Gilham, D E
Publicado 2014

Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy

por Griffiths, R W, Gilham, D E, Dangoor, A, Ramani, V, Clarke, N W, Stern, P L, Hawkins, R E
Publicado 2005

Bromodomain and extraterminal (BET) protein inhibitor, apabetalone, reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro

por Gilham, D, Smith, A L, Fu, L, Moore, D Y, Muralidharan, A, Reid, S P M, Stotz, S C, Johansson, J O, Sweeney, M, Wong, N C W, El-Gamal, D, Kulikowski, E
Publicado 2021